• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜透析治疗对2型糖尿病和非糖尿病终末期肾病患者动脉僵硬度及血管变化的影响。

Impact of peritoneal dialysis treatment on arterial stiffness and vascular changes in diabetic type 2 and nondiabetic patients with end-stage renal disease.

作者信息

Rebić Damir, Rašić Senija, Rebić Velma

机构信息

Clinic for Nephrology, Clinical Center of Sarajevo University, Bolnička 25, 71000 Sarajevo, Bosnia and Herzegovina.

出版信息

Int J Nephrol. 2013;2013:681454. doi: 10.1155/2013/681454. Epub 2013 Oct 22.

DOI:10.1155/2013/681454
PMID:24251038
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3819760/
Abstract

Diabetes mellitus (DM) is the leading cause of the end-stage renal disease (ESRD). Vascular diseases are the most common cause of morbidity and mortality in the chronic kidney disease. The aim of this study was to analyze the impact of peritoneal dialysis (PD) treatment on morphologic and hemodynamic vascular parameters of carotid arteries in diabetic type 2 and nondiabetic patients with ESRD during the period of one year after the start of PD treatment using ultrasonography of carotid arteries and their relation on uremia and PD inherent factors. Mean intima-media thickness, plaque score, peak systolic velocity, end-diastolic velocity, and carotid diameter significantly decreased 12 months after PD treatment start in both groups. Significant reduction in median serum endothelin-1 concentration after 12 months on PD treatment was observed in the group of patients with DM (7.6-5.9 pg/mL) and also in group of patients without DM (3.6-3.3 pg/mL). Also median nitric oxide concentration significantly increased after 12 months on PD compared to baseline levels both in patients with DM (25.0-34.3  μ mol/L) as was observed in patients without DM (49.6-56.5  μ mol/L). PD treatment, with the regulation of these vasoactive molecules and other vascular risk factors, significantly contributes to vascular remodeling, especially in DM patients.

摘要

糖尿病(DM)是终末期肾病(ESRD)的主要病因。血管疾病是慢性肾脏病发病和死亡的最常见原因。本研究的目的是在开始腹膜透析(PD)治疗一年期间,使用颈动脉超声分析PD治疗对2型糖尿病和非糖尿病ESRD患者颈动脉形态学和血流动力学血管参数的影响,以及它们与尿毒症和PD固有因素的关系。两组患者在开始PD治疗12个月后,平均内膜中层厚度、斑块评分、收缩期峰值流速、舒张末期流速和颈动脉直径均显著降低。在接受PD治疗12个月后,糖尿病患者组(7.6 - 5.9 pg/mL)和非糖尿病患者组(3.6 - 3.3 pg/mL)的血清内皮素-1中位数浓度均显著降低。同样,与基线水平相比,糖尿病患者(25.0 - 34.3 μmol/L)和非糖尿病患者(49.6 - 56.5 μmol/L)在接受PD治疗12个月后,一氧化氮中位数浓度均显著升高。PD治疗通过调节这些血管活性分子和其他血管危险因素,显著促进血管重塑,尤其是在糖尿病患者中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c378/3819760/3aadf474135b/IJN2013-681454.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c378/3819760/27da558d6490/IJN2013-681454.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c378/3819760/3aadf474135b/IJN2013-681454.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c378/3819760/27da558d6490/IJN2013-681454.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c378/3819760/3aadf474135b/IJN2013-681454.002.jpg

相似文献

1
Impact of peritoneal dialysis treatment on arterial stiffness and vascular changes in diabetic type 2 and nondiabetic patients with end-stage renal disease.腹膜透析治疗对2型糖尿病和非糖尿病终末期肾病患者动脉僵硬度及血管变化的影响。
Int J Nephrol. 2013;2013:681454. doi: 10.1155/2013/681454. Epub 2013 Oct 22.
2
The influence of risk factors in remodelling carotid arteries in patients undergoing peritoneal dialysis.腹膜透析患者颈动脉重塑的危险因素影响。
Bosn J Basic Med Sci. 2010 Apr;10 Suppl 1(Suppl 1):S79-82. doi: 10.17305/bjbms.2010.2654.
3
Hemodialysis in patients older than 65 years with end-stage renal failure--comparison of outcome in patients with and without diabetes.65岁以上终末期肾衰竭患者的血液透析——糖尿病患者与非糖尿病患者的预后比较。
Z Gerontol Geriatr. 2008 Apr;41(2):139-45. doi: 10.1007/s00391-007-0467-x. Epub 2008 Mar 11.
4
Biomarkers of cardiovascular remodeling in patients on peritoneal dialysis.腹膜透析患者心血管重塑的生物标志物
Am J Nephrol. 2014;39(2):92-9. doi: 10.1159/000358261. Epub 2014 Feb 4.
5
Vascular disease outcome and thrombocytosis in diabetic and nondiabetic end-stage renal disease patients on peritoneal dialysis.
Adv Perit Dial. 1994;10:77-80.
6
Carotid intimal thickness and flow-mediated dilatation in diabetic and nondiabetic continuous ambulatory peritoneal dialysis patients.糖尿病和非糖尿病持续非卧床腹膜透析患者的颈动脉内膜厚度及血流介导的血管舒张功能
Perit Dial Int. 2009 Feb;29 Suppl 2:S96-S101.
7
Coronary artery calcification, common carotid artery intima-media thickness and aortic pulse wave velocity in patients on peritoneal dialysis.腹膜透析患者的冠状动脉钙化、颈总动脉内膜中层厚度及主动脉脉搏波速度
Int J Artif Organs. 2006 Aug;29(8):736-44. doi: 10.1177/039139880602900802.
8
Association of dialysate calcium concentration with fetuin A level and carotid intima-media thickness in peritoneal dialysis patients.腹膜透析患者透析液钙浓度与胎球蛋白 A 水平及颈动脉内膜中层厚度的关系。
Ren Fail. 2014 Feb;36(1):65-8. doi: 10.3109/0886022X.2013.832309. Epub 2013 Sep 13.
9
Association of insulin resistance with arterial stiffness in nondiabetic peritoneal dialysis patients.非糖尿病腹膜透析患者胰岛素抵抗与动脉僵硬度的关系。
Int Urol Nephrol. 2012 Feb;44(1):255-62. doi: 10.1007/s11255-011-9984-z. Epub 2011 Jun 4.
10
Arterial endothelial function, carotid artery intima-media thickness and abdominal aortic calcification in diabetic and nondiabetic CKD stage 4-5 patients not on dialysis.糖尿病和非糖尿病 CKD 4-5 期未透析患者的动脉内皮功能、颈动脉内膜中层厚度和腹主动脉钙化。
Diabetes Res Clin Pract. 2021 Jan;171:108559. doi: 10.1016/j.diabres.2020.108559. Epub 2020 Nov 30.

引用本文的文献

1
Impact of low-dose urokinase in peritoneal dialysis on serum oxidative stress, nitric oxide and endothelin in cerebral infarction complicated with uremia.低剂量尿激酶在腹膜透析中对脑梗合并尿毒症患者血清氧化应激、一氧化氮及内皮素的影响
Int J Clin Exp Med. 2015 Jan 15;8(1):1333-41. eCollection 2015.

本文引用的文献

1
Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition.在接受透析治疗的患者中,原发性肾病为糖尿病和伴发糖尿病的患者的生存情况并无差异。
BMC Nephrol. 2011 Dec 19;12:69. doi: 10.1186/1471-2369-12-69.
2
Oxidative stress, endothelial function, carotid artery intimal thickness and their correlates among chronic peritoneal dialysis patients.慢性腹膜透析患者的氧化应激、内皮功能、颈动脉内膜厚度及其相关性
Indian J Nephrol. 2011 Oct;21(4):264-9. doi: 10.4103/0971-4065.83736.
3
Novel mechanisms of endothelial dysfunction in diabetes.
糖尿病中内皮功能障碍的新机制。
J Cardiovasc Dis Res. 2010 Apr;1(2):59-63. doi: 10.4103/0975-3583.64432.
4
Reduced residual renal function is associated with endothelial dysfunction in patients receiving peritoneal dialysis.残余肾功能降低与腹膜透析患者的内皮功能障碍有关。
Perit Dial Int. 2012 Mar-Apr;32(2):149-58. doi: 10.3747/pdi.2010.00111. Epub 2010 Sep 23.
5
Cardiovascular risk in the peritoneal dialysis patient.腹膜透析患者的心血管风险。
Nat Rev Nephrol. 2010 Aug;6(8):451-60. doi: 10.1038/nrneph.2010.68. Epub 2010 Jun 22.
6
Risk factors for mortality in diabetic peritoneal dialysis patients.糖尿病腹膜透析患者死亡的风险因素。
Nephrol Dial Transplant. 2010 Nov;25(11):3742-8. doi: 10.1093/ndt/gfq233. Epub 2010 May 5.
7
Correlation between endothelin-1 and atherosclerosis in chronic hemodialysis patients.慢性血液透析患者内皮素-1 与动脉粥样硬化的相关性。
J Nephrol. 2010 Sep-Oct;23(5):593-602.
8
Cardiovascular risk factors underestimate atherosclerotic burden in chronic kidney disease: usefulness of non-invasive tests in cardiovascular assessment.心血管危险因素在慢性肾脏病患者中低估了动脉粥样硬化负担:心血管评估中非侵入性检查的作用。
Nephrol Dial Transplant. 2010 Sep;25(9):3017-25. doi: 10.1093/ndt/gfq109. Epub 2010 Mar 17.
9
Carotid intimal thickness and flow-mediated dilatation in diabetic and nondiabetic continuous ambulatory peritoneal dialysis patients.糖尿病和非糖尿病持续非卧床腹膜透析患者的颈动脉内膜厚度及血流介导的血管舒张功能
Perit Dial Int. 2009 Feb;29 Suppl 2:S96-S101.
10
Endothelial dysfunction in diabetes mellitus.糖尿病中的内皮功能障碍。
Vasc Health Risk Manag. 2007;3(6):853-76.